SHG · Healthcare

Wuhan Keqian Biology Co Ltd (688526)

Biotechnology

Wuhan Keqian Biology Co Ltd (688526) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $6.85B, P/E ratio is 15.00, net margin is 43.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 688526

Market cap

$6.85B

P/E ratio

15.00

Gross profit (TTM)

$950.29M

Net margin

43.7%

Wuhan Keqian Biology Co Ltd (688526) — FAQ

What is Wuhan Keqian Biology Co Ltd's market cap?

Wuhan Keqian Biology Co Ltd (688526) has a reported market cap of $6.85B (data as of 2026-03-29).

What is 688526's P/E ratio?

The price-to-earnings (P/E) ratio for Wuhan Keqian Biology Co Ltd (688526) is 15.00 (data as of 2026-03-29).

Does Wuhan Keqian Biology Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Wuhan Keqian Biology Co Ltd (688526). Check the MyAverix Finance app for the latest dividend data.

What sector is Wuhan Keqian Biology Co Ltd in?

Wuhan Keqian Biology Co Ltd (688526) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 688526 listed on?

688526 is listed on SHG.

What is Wuhan Keqian Biology Co Ltd's net margin?

Wuhan Keqian Biology Co Ltd (688526) reports a net margin of 43.7% (data as of 2026-03-29).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Aimed Bio (0009K0) Celltrion (068270) Rznomics (476830)